Immix Biopharma, Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5
Rok finansowy 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 -90 0 0
Przychód Δ r/r 0.0% 0.0% 0.0% -inf% -100.0% 0.0%
Marża brutto -inf% -inf% -inf% 100.0% -inf% 0.0%
EBIT (mln) -1 -0 -1 -8 -16 -23
EBIT Δ r/r 0.0% -46.1% 197.9% 507.9% 96.4% 40.5%
EBIT (%) 0.0% 0.0% 0.0% 9.2% 0.0% nan
Koszty finansowe (mln) 0 0 0 0 0 0
EBITDA (mln) -1 -0 -1 -8 -16 -23
EBITDA(%) 0.0% 0.0% 0.0% 9.2% 0.0% nan
Podatek (mln) 0 0 0 0 0 0
Zysk Netto (mln) -1 -1 -24 -8 -15 -22
Zysk netto Δ r/r 0.0% 18.0% 2024.3% -66.2% 87.4% 40.1%
Zysk netto (%) 0.0% 0.0% 0.0% 9.2% 0.0% nan
EPS -0.13 -0.15 -1.84 -0.62 -0.89 -0.76
EPS (rozwodnione) -0.13 -0.15 -1.84 -0.62 -0.89 -0.76
Ilośc akcji (mln) 8 8 13 13 17 28
Ważona ilośc akcji (mln) 8 8 13 13 17 28
Waluta USD USD USD USD USD USD